Oropharyngeal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Oropharyngeal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers [Phase 1, Phase 2]
An early-phase clinical trial is evaluating TheraT Vectors vaccines in combination with chemotherapy for HPV16-associated head and neck canc…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial update evaluating either docetaxel plus cetuximab or adding atezolizumab to standard chemotherapy and radiation f…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) [Phase 2]
Update on a Phase 2 trial (OPERATION) investigating the omission of postoperative radiation in HPV-associated oropharyngeal squamous cell ca…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer [Phase 2]
This Phase 2 trial explores biomarker-guided reduction of radiation therapy dose following transoral robotic surgery for HPV-positive oropha…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the combination of ipilimumab, nivolumab, and radiation therapy in patients with HPV-positive advanced oro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Prospective Study for the Prognostic and Predictive Role of Circulating Tumor Cells in Patients With Oropharyngeal Squamous Cell Carcinoma: CTCO (Circulating Tumor Cells in the Oropharynx)
A completed prospective study evaluating the prognostic and predictive value of circulating tumor cells in patients with oropharyngeal squam…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Lattice-Based Radiotherapy and Chemoimmunotherapy for Oropharyngeal Squamous Cell Carcinoma [Phase 1, Phase 2]
This entry describes a Phase 1/2 clinical trial evaluating lattice-based radiotherapy in combination with chemoimmunotherapy for oropharynge…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with cetuximab for recurrent/metastatic head and neck squamous cell carcinoma; the stu…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV [Phase 3]
Clinical trial update on a nine-valent HPV vaccine intended to prevent persistent oral HPV infection in men with HIV; the Phase 3 study is c…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer [Phase 2]
A Phase 2 trial evaluating radiotherapy with carboplatin/paclitaxel and nivolumab for high-risk HPV-related oropharyngeal squamous cell carc…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma [Phase 1]
A Phase 1 clinical trial conducted by Cue Biopharma in patients with HPV16-positive recurrent or metastatic head and neck squamous cell carc…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: The SPOT-HPV Study
Clinical trial SPOT-HPV study has completed; this update does not report results.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Collagen Matrix in Oral Cancer Surgery
Clinical trial evaluating the use of a collagen matrix in oral cancer surgery has completed. The available snippet does not present trial re…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Optimisation of Potential Dental Implant Sites Protection for Rehabilitation in Patients With Head and Neck Cancer: Impact of Virtual Implants Visualisation on Dosimetry (OPPIDOM) [NA]
A clinical trial evaluating the impact of virtual implant visualization on dosimetry for protecting potential dental implant sites in head a…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Study of Hypoxia Measured in F-Miso PET/Scan and MRI in Patients With Squamous Cells Carcinoma [Phase 2]
Phase 2 trial evaluating hypoxia assessment in oropharyngeal squamous cell carcinoma using 18F-FMISO PET and MRI; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck. [Phase 2]
A Phase 2 clinical trial evaluating a peptide-based immunotherapy for head and neck squamous cell carcinoma was terminated; the update repor…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer [Phase 2]
A Phase 2 trial evaluating Vidutolimod in combination with cemiplimab for adults with advanced or metastatic cancers was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma [Phase 1]
Phase 1 study evaluating IRX-2 regimen with durvalumab for incurable head and neck squamous cell carcinoma has completed, including multiple…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPC [NA]
A completed clinical trial comparing fibula free-flap microreconstruction with or without PVP in patients with oropharyngeal or oral cavity …
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors [Phase 1]
Phase 1 basket trial evaluating customized autologous TCR-T cell therapies across multiple locally advanced or metastatic solid tumors, spon…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC [Phase 2]
A Phase 2 trial evaluating the combination of PDS0101 and pembrolizumab in HPV16-positive recurrent/metastatic head and neck cancer has comp…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial results discuss de-escalation radiotherapy in patients with low-risk HPV-related oropharyngeal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma
Completed real-world study evaluating first-line pembrolizumab or nivolumab in HPV-positive recurrent/metastatic oropharyngeal squamous cell…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Cisplatin or ImmunoTHerapy in Association With Definitive Radiotherapy in HPV-related oropharyngEal Squamous Cell Carcinoma: a Randomized Phase II Trial. [Phase 2]
A randomized Phase II trial comparing cisplatin-based radiotherapy to immunotherapy-based radiotherapy for HPV-related oropharyngeal squamou…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer [Phase 1]
Phase 1 trial evaluating the addition of M6620 (berzosertib; VX-970) to standard chemotherapy and radiation for head and neck cancers, inclu…